This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor.—
Fluorinated corticosteroids are used to treat and prevent a wide variety of dermatologic conditions even though many of them respond favorably to less potent topical preparations. Some patients continue to use their medications long after the primary condition has cleared. Many adverse side-effects have been reported with the use of topical fluorinated corticosteroids, and these agents can aggravate superficial fungus infections, acne vulgaris, acne rosacea, and other conditions.We examined eight patients who developed localized atrophy, telangiectasia, and purpura limited to areas where topical corticosteroids had been used. Four of the patients had psoriasis, two seborrheic dermatitis, one subacute systemic lupus erythematosus, and one chronic hand dermatitis. The period of treatment, ranging from ten months to five years, produced appreciable cosmetic deficits (Fig 1 and 2), and the skin was easily bruised and lacerated following minor trauma. Two patients used occlusion with plastic film in order
Chernosky ME, Schmidt JD. Adverse Side-Effects After Topical Fluorinated Corticosteroid Therapy. Arch Dermatol. 1973;108(1):132–133. doi:10.1001/archderm.1973.01620220086027
Customize your JAMA Network experience by selecting one or more topics from the list below.